Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company operates in two segments, Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs.
Read More…
Industry, Sector and Symbol
Industry Oil & gas field services, not elsewhere classified
Sub-IndustryN/A
SectorOils/Energy
Phone31-20-420-3191
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$700.85 million
Profitability
Miscellaneous
Employees4,700
Next Earnings Date10/23/2019 (Estimated)
OptionableOptionable
Core Laboratories (NYSE:CLB) Frequently Asked Questions
What is Core Laboratories' stock symbol?
Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."
How often does Core Laboratories pay dividends? What is the dividend yield for Core Laboratories?
Core Laboratories declared a quarterly dividend on Friday, July 12th. Stockholders of record on Monday, July 22nd will be given a dividend of $0.55 per share on Monday, August 12th. This represents a $2.20 annualized dividend and a dividend yield of 4.38%. The ex-dividend date is Friday, July 19th. View Core Laboratories' Dividend History.
How were Core Laboratories' earnings last quarter?
Core Laboratories (NYSE:CLB) released its quarterly earnings results on Wednesday, July, 24th. The oil and gas company reported $0.46 EPS for the quarter, hitting the Thomson Reuters' consensus estimate of $0.46. The oil and gas company earned $169.04 million during the quarter, compared to analyst estimates of $173.46 million. Core Laboratories had a return on equity of 51.19% and a net margin of 14.30%. The firm's revenue was down 3.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.59 EPS. View Core Laboratories' Earnings History.
When is Core Laboratories' next earnings date?
What guidance has Core Laboratories issued on next quarter's earnings?
Core Laboratories updated its third quarter earnings guidance on Wednesday, July, 24th. The company provided earnings per share (EPS) guidance of $0.48-0.52 for the period, compared to the Thomson Reuters consensus estimate of $0.50. The company issued revenue guidance of $171-175 million, compared to the consensus revenue estimate of $179.03 million.
What price target have analysts set for CLB?
14 brokers have issued twelve-month target prices for Core Laboratories' shares. Their predictions range from $51.00 to $120.00. On average, they expect Core Laboratories' share price to reach $74.1818 in the next twelve months. This suggests a possible upside of 47.7% from the stock's current price. View Analyst Price Targets for Core Laboratories.
What is the consensus analysts' recommendation for Core Laboratories?
14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last year. There are currently 1 sell rating, 7 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Core Laboratories.
Has Core Laboratories been receiving favorable news coverage?
News stories about CLB stock have trended negative on Thursday, according to InfoTrie. InfoTrie identifies negative and positive press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Core Laboratories earned a coverage optimism score of -2.9 on InfoTrie's scale. They also assigned headlines about the oil and gas company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the next several days. View News Stories for Core Laboratories.
Are investors shorting Core Laboratories?
Core Laboratories saw a decrease in short interest in the month of August. As of August 31st, there was short interest totalling 3,306,800 shares, a decrease of 13.4% from the July 31st total of 3,819,300 shares. Based on an average daily volume of 689,200 shares, the days-to-cover ratio is presently 4.8 days. Approximately 7.6% of the company's shares are short sold. View Core Laboratories' Current Options Chain.
Who are some of Core Laboratories' key competitors?
Some companies that are related to Core Laboratories include Subsea 7 (SUBCY), Oceaneering International (OII), RPC (RES), Helix Energy Solutions Group (HLX), Liberty Oilfield Services (LBRT), SemGroup (SEMG), Propetro (PUMP), Franks International (FI), Hurricane Energy (HRCXF), Select Energy Services (WTTR), C&J Energy Services (CJ), National Energy Services Reunited (NESR), Keane Group (FRAC), FTS International (FTSI) and North American Construction Group (NOA).
What other stocks do shareholders of Core Laboratories own?
Who are Core Laboratories' key executives?
Core Laboratories' management team includes the folowing people:
- Mr. David M. Demshur, CEO & Chairman of Supervisory Board (Age 64)
- Mr. Lawrence V. Bruno, COO, Pres & Supervisory Director (Age 59)
- Mr. Christopher Scott Hill, Sr. VP & CFO (Age 49)
- Mr. Kevin G. Daniels, Chief Accounting Officer, Treasurer & VP (Age 55)
- Ms. Gwendolyn Y. Schreffler M.B.A., Sr. VP of Corp. Devel. & Investor Relations
Who are Core Laboratories' major shareholders?
Core Laboratories' stock is owned by many different of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (9.50%), BlackRock Inc. (7.30%), Earnest Partners LLC (5.20%), Kayne Anderson Rudnick Investment Management LLC (3.53%), Van ECK Associates Corp (2.87%) and JPMorgan Chase & Co. (2.76%). Company insiders that own Core Laboratories stock include Gregory Barry Barnett, Jan Willem Sodderland and Kevin Daniels. View Institutional Ownership Trends for Core Laboratories.
Which institutional investors are selling Core Laboratories stock?
CLB stock was sold by a variety of institutional investors in the last quarter, including Evercore Wealth Management LLC, Envestnet Asset Management Inc., Parametric Portfolio Associates LLC, Northern Trust Corp, Schroder Investment Management Group, Russell Investments Group Ltd., Grandeur Peak Global Advisors LLC and BNP Paribas Arbitrage SA. View Insider Buying and Selling for Core Laboratories.
Which institutional investors are buying Core Laboratories stock?
CLB stock was acquired by a variety of institutional investors in the last quarter, including Van ECK Associates Corp, Manning & Napier Group LLC, Earnest Partners LLC, Granite Investment Partners LLC, Teacher Retirement System of Texas, Marshall Wace North America L.P., Steadfast Capital Management LP and Bell Asset Management Ltd. Company insiders that have bought Core Laboratories stock in the last two years include Gregory Barry Barnett and Jan Willem Sodderland. View Insider Buying and Selling for Core Laboratories.
How do I buy shares of Core Laboratories?
Shares of CLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Core Laboratories' stock price today?
One share of CLB stock can currently be purchased for approximately $50.23.
How big of a company is Core Laboratories?
Core Laboratories has a market capitalization of $2.23 billion and generates $700.85 million in revenue each year. The oil and gas company earns $79.52 million in net income (profit) each year or $2.28 on an earnings per share basis. Core Laboratories employs 4,700 workers across the globe.View Additional Information About Core Laboratories.
What is Core Laboratories' official website?
How can I contact Core Laboratories?
Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The oil and gas company can be reached via phone at 31-20-420-3191 or via email at [email protected]
MarketBeat Community Rating for Core Laboratories (NYSE CLB)
MarketBeat's community ratings are surveys of what our community members think about Core Laboratories and other stocks. Vote "Outperform" if you believe CLB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLB will underperform the S&P 500 over the long term. You may vote once every thirty days.
